(Q38038274)

English

Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review

scientific article published on 28 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

0 references

author name string

R Cable

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

N Lelie

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

A Bird

3

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

28 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

93-99

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Characterization of occult hepatitis B virus strains in South African blood donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalized black children of Natal/KwaZulu, South Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

HBsAg non-reactive HBV infection in blood donors: Transmission and pathogenicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2012.01640.X

21 January 2018

Identifiers

10.1111/J.1423-0410.2012.01640.X

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38038274&oldid=1738270129"